News
Mandatory Offer
23.12.2002 - Following the termination of former CEO Graham Waters` employment with NUT, Lars Hoie, member of the Board of Directors of NUT, has on Dec 23, 2002 acquired 750.000 shares in NUT .....
Read more about Mandatory OfferOrganisational Change
23.12.2002 - As previously announced, Graham Waters, CEO of NUT, has resigned from NUT effective April 2003....
Read more about Organisational ChangeThird quarter results 2002
31.10.2002 - Nutri Pharma ASA (OSE: NUT) today announced that as a result of its JV with Nycomed Pharma revenues grew by 226% from NOK 12.4 million as of September 30 2001 to NOK 40.5 million in the same period 2002 while the operating result has improved from NOK –98.2 million to NOK –58.5 million....
Read more about Third quarter results 2002Resignation of CEO
15.10.2002 - Graham Waters, the CEO of Nutri Pharma has informed the Board of Directors that he has resigned from his position as CEO with effect from April 2003....
Read more about Resignation of CEOSecond quarter results 2002
25.07.2002 - Nutri Pharma ASA (OSE: NUT) today announced that as a result of its JV with Nycomed Pharma revenues grew by 263% from NOK 7.9 million in the first half of 2001 to NOK 28.7 million in the first half of 2002....
Read more about Second quarter results 2002First quarter results 2002
24.04.2002 - Nutri Pharma ASA (OSE: NUT) today announced that as a result of its JV with Nycomed Pharma revenues grew by 239% from NOK 4 million in Q1 2001 to NOK 13.4 million in Q1 2002....
Read more about First quarter results 2002Summary of Annual General Meeting (AGM)
24.04.2002 - The Annual General Meeting (AGM) of Nutri Pharma ASA today approved the board of directors` proposal for annual accounts and directors` report including the board of directors` proposal for coverage of the loss for 2001. ...
Read more about Summary of Annual General Meeting (AGM)Nutri Pharma announces results for fourth quarter 2001 and preliminary results for 2001
07.02.2002 - Nutri Pharma ASA (OSE: NUT) today announced 105% growth in fourth quarter revenues and 126% growth in preliminary revenues for 2001 compared to 2000....
Read more about Nutri Pharma announces results for fourth quarter 2001 and preliminary results for 2001